ANTHONY PRINCIPI

S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09

S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09

Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology Follow on Biologics Medicare Part D Health care Reform Physician Payment Disclosure S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act H.R. 4489 - FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H. Con Res 85 - Budget Resolution 2010 H.R. 4213 - Tax Extenders Act

Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009

S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09

Deferral Deferral for active-financing income- extension S. 1203 - R& E Tax Credit Extension and Enhancement H.R. 422 - R&E Tax Credit Extension and Enhancement H.R. 2098 - CFC Look Through Extension

Administration budget proposal, deferral and other international tax issues H.R.3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010

S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act

Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009

H.R. 198 - Healthcare Tax Deduction Act of 2009 H.R. 422 - R&E tax credit extension and Enhancement H.R. 2098 - CFC Look Through Extension S. 1203 - R& E tax credit extension and Enhancement Deferral Deferral for active-financing income- extension Tax Treaties - France, New Zealand, Malta

Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D

S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09

H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia market access (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Finland Patent Issues Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation

H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act

H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance

S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act

H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act

Wyeth Acquisition

S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act

Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D

H.R. 1 - The American Recovery and Reinvestment Act 2009 S. Con Res 13 - Budget Reconciliation FY 10 H. Con Res 85 - Budget Reconciliation FY 10 Administration budget proposal, deferral and other international tax issues

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation

S. 515, Patent Reform Act of 2009 S. 299, Expert Patent Courts Pilot Program Act, 1/09 S. 369, Preserve Access to Affordable Generics, 2/09 S. 515 Patent Reform Act, 3/09 S.610, Patent Reform Act, 3/09 HR 1260, Patent Reform Act, 3/09 HR 1706, Protecting Consumer Access to Generics Drug Act, 3/09 HR 1548, Pathway for Biosimilars Act

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology Follow-on Biologics S. 4 - Comprehensive Health reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act HR 2, Children's Health Insurance Program Reauthorization Act of 2009 S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 - Pathway for Biosimilars Act S.717 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H. Con Res 85 - Budget Reconciliation Health Reform Initiatives Health Information Technology Comparative Effectiveness Research Follow on Biologics

HR 1, American Recovery and Reinvestment Act of 2009 - general corporate tax issues HR 198, Healthcare Tax Deduction Act of 2009 - general corporate tax issues HR 422, R&D tax credit extension and Enhancement - R&D tax credit R&D tax credit extension and Enhancement (Senate) - R&D tax credit Deferral

S.80, Pharmaceutic Market Access Act, 1/09 HR 91, Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 HR 163, The Prescription Drug Affordability Act, 1/09 S. 501, Fair prescription Drug Competition Act, 3/09 S. 767, Independent Drug Education and Outreach Act, 4/09 HR 573, Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09 HR 1427, Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 HR 1548, Pathway for Biosimilars Act, 3/09 HR 759, The Food, drug and Cosmetic Globalization Act, 1/09

H.R. 198 - Healthcare Tax Deduction Act of 2009 H.R. 422 - R&E tax credit extension and Enhancement H.R. 2098 - CFC Look Through Extension S. 1203 - R& E tax credit extension and Enhancement Deferral Deferral for active-financing income- extension Tax Treaties - France, New Zealand, Malta

Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia market access (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Finland Patent Issues Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation

S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act

H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act

H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance

H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance

Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act H.R. 3962 - Affordable Healthcare for America Act H.R. 3590 - Patient Protection and Affordable Care Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D

Administration budget proposal, deferral and other international tax issues H.R.3293 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2010

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia market access (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Finland Patent Issues Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation

H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act

S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act

Wyeth Acquisition

H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) H.R. 2502 - Comparative Effectiveness Research Act H.R. 3200 - America's Affordable Heath Choices Act of 2009. H.R. 3675 - National Quality Cancer care Demonstration Project Act of 2009 S. 1630 - Affordable Access to Prescription Medicine Act of 2009 S. 1679 - Affordable Heath Choices Act of 2009 Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance

Wyeth Acquisition

S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia market access (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation

H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act

Veterans Healthcare issues Health Reform Comparative Effectiveness Research Health Information Technology S. 4 - Comprehensive Health Reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act S. 717 - 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 2 - Children's Health Insurance Program Reauthorization Act of 2009 H.R. 1548 - Pathway for Biosimilars Act H. Con Res 85 - Budget Reconciliation H.R. 2366 Cancer Drug Coverage Parity Act 0f 2009 H.R. 1548 - The Pathway for Biosimilars Act H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 3200 - America's Affordable Health Choice Act H.R. 2366 - Cancer Drug Coverage parity Act Health Information Technology Comparative Effectiveness Research Health Care Reform Proposals Follow on Biologics Medicare Part D

S.80, Pharmaceutic Market Access Act, 1/09 HR 91, Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 HR 163, The Prescription Drug Affordability Act, 1/09 S. 501, Fair prescription Drug Competition Act, 3/09 S. 767, Independent Drug Education and Outreach Act, 4/09 HR 573, Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09 HR 1427, Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 HR 1548, Pathway for Biosimilars Act, 3/09 HR 759, The Food, drug and Cosmetic Globalization Act, 1/09

HR 1, American Recovery and Reinvestment Act of 2009 - general corporate tax issues HR 198, Healthcare Tax Deduction Act of 2009 - general corporate tax issues HR 422, R&D tax credit extension and Enhancement - R&D tax credit R&D tax credit extension and Enhancement (Senate) - R&D tax credit Deferral

S. Con Res 13 - Budget Reconciliation FY 10 H. Con Res 85 - Budget Reconciliation FY 10 Administration budget proposal, deferral and other international tax issues H.R. 1 - The American Recovery and Reinvestment Act 2009

HR 684, The Medicare Prescription Drug Savings and Choice Act of 2009 S. 75, Generics First Act of 2009 (Part D) HR 574, Medicare Home Infusion Therapy Coverage Act of 2009 Medicare Prescription Drug Benefit Implementation - retain Medicaid Rebates - retain the general issues section Medicare Coverage Average Manufacturer Price Regulation

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology Follow-on Biologics S. 4 - Comprehensive Health reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act HR 2, Children's Health Insurance Program Reauthorization Act of 2009 S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 - Pathway for Biosimilars Act S.717 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H. Con Res 85 - Budget Reconciliation Health Reform Initiatives Health Information Technology Comparative Effectiveness Research Follow on Biologics

Environmental issues related to pharmaceutical manufacturing

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation

S. Con Res 13 - Budget Reconciliation FY 10 H. Con Res 85 - Budget Reconciliation FY 10 Administration budget proposal, deferral and other international tax issues H.R. 1 - The American Recovery and Reinvestment Act 2009

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology Follow-on Biologics S. 4 - Comprehensive Health reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act HR 2, Children's Health Insurance Program Reauthorization Act of 2009 S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 - Pathway for Biosimilars Act S.717 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H. Con Res 85 - Budget Reconciliation Health Reform Initiatives Health Information Technology Comparative Effectiveness Research Follow on Biologics

HR 1, American Recovery and Reinvestment Act of 2009 - general corporate tax issues HR 198, Healthcare Tax Deduction Act of 2009 - general corporate tax issues HR 422, R&D tax credit extension and Enhancement - R&D tax credit R&D tax credit extension and Enhancement (Senate) - R&D tax credit Deferral

S.80, Pharmaceutic Market Access Act, 1/09 HR 91, Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 HR 163, The Prescription Drug Affordability Act, 1/09 S. 501, Fair prescription Drug Competition Act, 3/09 S. 767, Independent Drug Education and Outreach Act, 4/09 HR 573, Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09 HR 1427, Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 HR 1548, Pathway for Biosimilars Act, 3/09 HR 759, The Food, drug and Cosmetic Globalization Act, 1/09

Wyeth Acquisition

H.R. 684 - The Medicare Prescription Drug Savings and Choice Act of 2009 H.R. 574 - Medicare Home Infusion Therapy Coverage Act of 2009 S. 75 - Generics First Act of 2009 (Part D) Medicare Prescription Drug Benefit Implementation Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Medicare Secondary Payer Guidance

S.80 - Pharmaceutic Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 767 - Independent Drug Education and Outreach Act, 4/09 S. 882 - Drug and Device Accountability Act H.R. 163 - The Prescription Drug Affordability Act, 1/09 H.R. 91 - Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1256 - Family Smoking Prevention: Tobacco Control Act

H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 1549 - The Preservation of Antibiotics for Medical Treatment Act

US- China Trade Dialogues (JCCT) - market access and IP issues Trans Pacific Partnership talks US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia market access (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues Taiwan - Market Access Issues (TIFA talks) APEC Life Sciences Innovation Forum Mexico IP and market access issues Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation Trade Enforcement Legislation

S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 S. 515 - Patent Reform Act, 3/09 S.610 - Patent Reform Act, 3/09 H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act

S.80, Pharmaceutic Market Access Act, 1/09 HR 91, Shipment of Prescription Drugs between the States and the Virgin Islands, 1/09 HR 163, The Prescription Drug Affordability Act, 1/09 S. 501, Fair prescription Drug Competition Act, 3/09 S. 767, Independent Drug Education and Outreach Act, 4/09 HR 573, Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09 HR 1427, Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 HR 1548, Pathway for Biosimilars Act, 3/09 HR 759, The Food, drug and Cosmetic Globalization Act, 1/09

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Health Information Technology Follow-on Biologics S. 4 - Comprehensive Health reform Act (1/09) S. 45 - Health Liability Reduction Act (1/09) S. 301 - Physician Payments Sunshine Act (1/09) H.R. 15 - National Health Insurance Act (1/09) H.R. 193 - AmeriCare Act (1/09) S. 501 - Fair Prescription Drug Competition Act (3/09) H.R. 1 - The American Recovery and Reinvestment Act H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act HR 2, Children's Health Insurance Program Reauthorization Act of 2009 S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 - Pathway for Biosimilars Act S.717 21st Century Cancer ALERT Act S. Con Res 13 - Budget Reconciliation H. Con Res 85 - Budget Reconciliation Health Reform Initiatives Health Information Technology Comparative Effectiveness Research Follow on Biologics

HR 684, The Medicare Prescription Drug Savings and Choice Act of 2009 S. 75, Generics First Act of 2009 (Part D) HR 574, Medicare Home Infusion Therapy Coverage Act of 2009 Medicare Prescription Drug Benefit Implementation - retain Medicaid Rebates - retain the general issues section Medicare Coverage Average Manufacturer Price Regulation

S. Con Res 13 - Budget Reconciliation FY 10 H. Con Res 85 - Budget Reconciliation FY 10 Administration budget proposal, deferral and other international tax issues H.R. 1 - The American Recovery and Reinvestment Act 2009

Environmental issues related to pharmaceutical manufacturing

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007 HR 1014 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 3963 - Childrens Health Insurance Program Extension & Improvement S 558 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 1424, Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid Medicare prescription drug benefit implementation (no bills) - retain Medicaid rebates (no bills) - retain the general issues section Medicaid coverage (no bills) Average Manufacturer Price Regulation HR. 3162, Childrens Health and Medicare Protection Act 2007 HR. 976/2963, Childrens Health Insurance Program Reauthorization 2007 HR. 118, To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries 2/07 H.R. 6331 Medicare Improvements for Patients & Providers Act HR 2567, Medicare Home Infusion Therapy Coverage Act of 2007

S. 2041 False Claims Act Correction Act of 2007 HR. 4854 False Claims Act Correction Act of 2007

HR 4279 (Pro-IP Act) Global intellectual property rights protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008

HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07

HR 2850, Green Chemistry Research and Development Act of 2007, environmental conservation HR 6451 Drug Free Water Act of 2008, Environmental Conservation HR 6820 Water Study Act of 2008, Environmental Conservation

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act S. 3325, PL-110-403 (10/13/08) Intellectual Property Enforcement Act

HR. 2138, R&D tax credit extension 5/07 S. 41, R&D tax credit extension 1/07 S. 41, S. 2209, HR. 1712, R&E tax credit 2007 - all three Tax treaties with Iceland, Bulgaria and Canada H.R. 1424 - Emergency Economic Stabilizaton Act of 2008 H.R. 3997 - Emergency Economic Stabilizaton Act of 2008 S. 1974, H.R. 3361 - Pension technicals

HR 2850, Green Chemistry Research and Development Act of 2007, environmental conservation HR 6451 Drug Free Water Act of 2008, Environmental Conservation HR 6820 Water Study Act of 2008, Environmental Conservation

HR. 6432 - Animal Drug User Fee Amendments of 2008. HR. 3161 - Agriculture Appropriations, pharmaceutical counterfeiting, importation - 08

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act

HR 4279 (Pro-IP Act) Global intellectual property rights protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues

HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007 HR 1014 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 3963 - Childrens Health Insurance Program Extension & Improvement S 558 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 1424, Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid Medicare prescription drug benefit implementation (no bills) - retain Medicaid rebates (no bills) - retain the general issues section Medicaid coverage (no bills) Average Manufacturer Price Regulation HR. 3162, Childrens Health and Medicare Protection Act 2007 HR. 976/2963, Childrens Health Insurance Program Reauthorization 2007 HR. 118, To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries 2/07 H.R. 6331 Medicare Improvements for Patients & Providers Act HR 2567, Medicare Home Infusion Therapy Coverage Act of 2007

H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act Agriculture, Rural Development, FDA and Related Agencies Appropriations, pharmaceutical counterfeiting, importation FY 07- No Bill Number S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07 S. 3633 - Transparency in Drug Labeling Act (country of origin labeling), September 17, 2008

HR. 2138, R&D tax credit extension 5/07 S. 41, R&D tax credit extension 1/07 S. 41, S. 2209, HR. 1712, R&E tax credit 2007 - all three Tax treaties with Ireland, Bulgaria and Canada H.R. 1424 - Emergency Economic Stabilizaton Act of 2008 H.R. 3997 - Emergency Economic Stabilizaton Act of 2008

S. 2041 False Claims Act Correction Act of 2007 HR. 4854 False Claims Act Correction Act of 2007

S. 2041 False Claims Act Correction Act of 2007 HR. 4854 False Claims Act Correction Act of 2007

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research Genetic Information Non-Discrimination S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) H.R. 6331 Medicare Improvements for Patients & Providers Act H.R. 6376 and H.R. 6378 - Strengthening FDA Integrity Act (6/08) S. 877 - Stop Abuse of Growth Hormone Act (3/07) H.R. 4911 - Human Growth Hormone Restriction Act (12/07) H.R. 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or The Pro(TECH)T Act of 2008 H.R. 6898 - the Health-e Information Technology Act of 2008 S. 3396 - Independent Drug Education and Outreach Act of 2008

HR. 2138, R&D tax credit extension 5/07 S. 41, R&D tax credit extension 1/07 S. 41, S. 2209, HR. 1712, R&E tax credit 2007 - all three Tax treaties with Ireland, Bulgaria and Canada H.R. 1424 - Emergency Economic Stabilizaton Act of 2008 H.R. 3997 - Emergency Economic Stabilizaton Act of 2008

HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07

HR 4279 (Pro-IP Act) Global intellectual property rights protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession Saudi Arabia Patent Issues (no bills) South Africa Pricing & Patent Issues (no bills) Israel Patent Issues (no bills) Czech Republic Market Access Finland Patent Issues

HR. 6432 - Animal Drug User Fee Amendments of 2008. HR. 3161 - Agriculture Appropriations, pharmaceutical counterfeiting, importation - 08

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007 HR 1014 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 3963 - Childrens Health Insurance Program Extension & Improvement S 558 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 1424, Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid Medicare prescription drug benefit implementation (no bills) - retain Medicaid rebates (no bills) - retain the general issues section Medicaid coverage (no bills) Average Manufacturer Price Regulation HR. 3162, Childrens Health and Medicare Protection Act 2007 HR. 976/2963, Childrens Health Insurance Program Reauthorization 2007 HR. 118, To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries 2/07 H.R. 6331 Medicare Improvements for Patients & Providers Act HR 2567, Medicare Home Infusion Therapy Coverage Act of 2007

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act

Animal Drug User Fee Act Reauthorization - no bill yet. HR. 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation - 08

HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07

HR 4279 (Pro-IP Act) Global intellectual property rights protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession

HR 2850, Green Chemistry Research and Development Act of 2007, environmental conservation

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007 HR 1014 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 3963 - Childrens Health Insurance Program Extension & Improvement S 558 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 1424, Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid Medicare prescription drug benefit implementation (no bills) - retain Medicaid rebates (no bills) - retain the general issues section Medicaid coverage (no bills) Average Manufacturer Price Regulation HR. 3162, Childrens Health and Medicare Protection Act 2007 HR. 976/2963, Childrens Health Insurance Program Reauthorization 2007 HR. 118, To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries 2/07 H.R. 6331 Medicare Improvements for Patients & Providers Act

H. Con. Res 312 -Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental FY 08 BR S. Con Res 70 - Budget Reconciliation, pharmaceutical counterfeiting, importation FY 08 HR 3610 Food & Drug Import Safety Act Agriculture, Rural Development, FDA and Related Agencies Appropriations, pharmaceutical counterfeiting, importation FY 07- No Bill Number S. Con Res. 18, budget reconciliaton, pharmaceutical counterfeiting, importation 3/07 S. Con Res. 21, budget resolution, non-interference 5/07 HR. 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR. 3161, FY 2008 Agriculture Appropriations Bill (importation) S. 1710, Labor/HHS Appropriations 6/07

HR. 1432, Preserve Access to Affordable Generics Act (settlements) 3/07 S. 316, Preserve Access to Affordable Generics Act (settlements) 3/07 HR 1902, Protecting Consumer Access to Generic Drugs Act (4/07) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) 1/07 HR 780, Counterfeit Drug Prevention Act of 2007 3/07 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) 2/07 HR 1038, Access to Life-Saving Medication Act HR 5629, Pathway For Biosimilars Act S. 1145, Patent Reform Act (4/07) HR 1908, Patent Reform Act

HR 780, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 2699, Neglected Diseases Elimination Act, promote R&D S 484, Enhancing Drug Safety and Innovation Act 2006 S 1082, FDA Revitalization Act 3/07 HR 2900, FDA Amendments Act 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act 3/07 HR. 380, Pharmaceutical Market Access and Drug Safety Act 2/07

Global intellectual property rights protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) HR 4279 (Pro-IP Act) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills) Poland market access (no bills) Russia permanent normal trade relations (no bills) Turkey Market Access (no bills) Free Trade Agreement Implementation Legislation (Peru, Columbia, Panama, Korea, Israel, Saudi Arabia) OECD Accession

HR 2850, Green Chemistry Research and Development Act of 2007, environmental conservation

Animal Drug User Fee Act Reauthorization - no bill yet. HR. 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation - 08

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007 HR 1014 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 3963 - Childrens Health Insurance Program Extension & Improvement S 558 - Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid HR 1424, Paul Wellstone Mental Health & Addiction Equity Act of 2007- Medicaid Medicare prescription drug benefit implementation (no bills) - retain Medicaid rebates (no bills) - retain the general issues section Medicaid coverage (no bills) Average Manufacturer Price Regulation HR. 3162, Childrens Health and Medicare Protection Act 2007 HR. 976/2963, Childrens Health Insurance Program Reauthorization 2007 HR. 118, To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate prices for part D covered drugs for Medicare beneficiaries 2/07

Veterans Healthcare issues Electronic Prescribing Comparative Effectiveness Research S. 2408, Medicare Electronic Medication and Safety Protection Act 2007 HR. 4296, Medicare Electronic Medication and Safety Protection Act 12/07 HR. 3800, Promoting Health Information Technology Act 10/07 HR. 2406, (no title) authorize the NIST to increase its efforts in support of the integration of the healthcare information enterprise in the United States 11/07 S. 1693, The Wired for Health Care Quality Act 10/07 S. 438, Fair Prescription Drug Competition Act 1/07 S. 1082, Food and Drug Administration Revitalization Act 5/07 HR. 806 2/07 S. 358, Genetic Information Nondiscrimination Act 4/07 S. 1432, Preserve Access to Affordable Generics Act 5/07 S. 316, Preserve Access to Affordable Generics Act 3/07 S. 2029 Physician Payments Sunshine Act HR 5605 Physician Payments Sunshine Act HR 962 Preservation of Antibioties for Medical Treatment Act S. 349 Preservation of Antibioties for Medical Treatment Act S. 2313 Strategies to Address Antimicrobial Resistance HR 3697 Strategies to Address Antimicrobial Resistance HR 1424. The Paul Wellstone Mental Health and Addiction Equity Act S 2731, The Tom Lantos and Henry J. Hyde United States Global Leadership Against HIVAIDS, Tuberculosis, and Malaria Reauthorization Act (Also HR 5501) E-Meds Act

S. 1547, National Defense Authorization Act for FY 2008 HR. 1585, National Defense Authorization Act for FY 2008 S. 1547, Defense Authorization Act of FY 2008 HR. 1585, Defense Authorization Act of FY 2008

HR. 2206, Veterinarh Workforce Expansion Act of 2005, increased funding for veterinary schools HR. 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation S. 914, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools

HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting

S.Con Res. 21, Medicare and Medicaid, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental H. Con Res 99, Budget Reconciliation, pharmaceutical counterfeiting, importation HR. 2744, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006,

HR. 1432, Preserve Access to Affordable Generics Act (settlements) S. 316, Preserve Access to Affordable Generics Act (settlements)

HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 S 3, Medicare Prescription Drug Price Negotiation Act of 2007

* Intellectual property protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) Intellectual property protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills)

HR 2406, (no title) authorize the NIST to increase its efforts in support of the integration the healthcare information enterprise in the United States. S 1693, The Wired for Heath Care Quality Act S. 438, Fair Prescription Drug Competition Act S. 1082, Food and Drug Administration Revitalization Act HR 806 S 358, Genetic Information Nondiscrimination Act S 1693, Wired for Health Quality Act HR 1432, Preserve Access to Affordable Generics Act S 316, Preserve Access to Affordable Generics Act HR 2406 Veterans' Healthcare issues

S 3807, Enhancing Drug Safety and Innovation Act of 2006, drug safety, DTC

HR 2850, Green Chemistry Research and Development Act of 2007, environmental conservation

Intellectual property protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills) US-Panama Free Trade Agreement (no bills) Norway Patent issues (no bills)

H Con Res 99, Budget Reconciliation, pharmaceutical counterfeiting, importation S.Con Res 21, Budget Reconciliation, pharmaceutical counterfeiting, importation, AIDS Drug Assistance Programs Supplemental S Con Res 18, Budget reconciliation, pharmaceutical counterfeiting, importation S Con Res 21, Budget resolution, non-interference HR 3043, Department of Labor, Health and Human Services, and Education, and related Agencies Appropriation Act FY 2008, Pharmaceutical counterfeiting, Importation HR 3161, FY 2008 Agriculture Appropriations Bill (importation)

HR 1432, Preserve Access to Affordable Generics Act (settlements) S 316, Preserve Access to Affordable Generics Act (settlements) S 2300, Lower PRICED Drugs Act, legislation pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To Amend Title 35, United States Code, to confirm certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 438, Fair Prescription Drug Competition Act (ban authorized generics) HR 780, Counterfeit Drug Prevention Act of 2007 HR 1908, Patent Reform Act of 2007 S 1145, Patent Reform Act of 2007 S 623, Access to Life-Saving Medication Act (FOBS) HR 1038, Access to Life-Saving Medication Act

HR 2206, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools HR 3161, Agriculture Appropriations, pharmaceutical counterfeiting, importation S 914, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools

HR 3283, Agreement The United States Trade Rights Enforcement Act of 2005, intellectual property, market access, foreign price controls S 307, Agreement The United States Trade Rights Enforcement Act of 2005, intellectual property, market access, foreign price controls Intellectual property protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) HR 2862, Science, State, Justice Appropriations, market access HR 3045, Dominican Republic-Central America-United States Free Trade Agreement Implementation Act, intellectual property, foreign price controls, market access restrictions

HR 3010, Labor, HHS Appropriation, prescription drug benefit, price controls HR 712, Medicare Prescription Drug Sensibility Act, prescription drug benefit S 1932, Deficit Reduction Omnibus Reconciliation Act, prescription drug payment issues HR 5297, Improving Access to Medicare Part D Act of 2006, prescription drug benefit Medicare prescription drug benefit implementation (no bills) Medicaid rebates (no bills) Medicaid coverage (no bills)

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeiting Drug Prevention Act, pharmaceutical counterfeiting HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

International repatriation tax (no bills)

HR 2206, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools HR 2744, Agriculture Appropriations, pharmaceutical counterfeiting, importation S 914, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools

S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical countefeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 3010, Department of Labor, Health and Human Service, and Education, and Related Agencies Appropriations Act, 2006, access to prescription drugs HR 3971, Social Services Emergency Relief and Recovery Act of 2005, access to prescription drugs HR 5993, Authorized Generics Prohibition, authorized generics S 3695, Authorized Generics Prohibition, authorized generics HR 4157, Better Health Information System Act, health information technology HR 4642, Wired for Health Act, health information technology S 1418, Wired for Health Act, health information technology S 2300, Lower Priced Drug Act, generic drug access HR 5005, Ryan White Care Act, reauthorization S 2339, Ryan White Care Act, reauthorization HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importaion, patent issues

S 5, The Class Action Fairness Act of 2005, class action reform S 852, The Fairness in Asbestos Injury Resolution Act of 2005, asbestos litigation

HR 3010, Labor, HHS Appropriations, prescription drug benefit, price controls HR 712, Medicare Prescription Drug Sensibility Act, prescription drug benefit S 1932, Deficit Reduction Omnibus Reconciliation Act, prescription drug payment issues S 438, Medicare Access to Rehabilitation Services Act of 2005 Medicare prescription drug benefit implementation (no bills) Medicaid rebates (no bills) Medicaid coverage (no bills)

HR 2862, Science, State, Justice Appropriations, market access HR 3045, Dominican Republic-Central America-United States Free Trade Agreement Implementation Act, Intellectual property, foreign price controls, market access restrictions HR 3283, Agreement The United States Trade Rights Enforcement Act of 2005, intellectual property, market access, foreign price controls S 307, Agreement The United States Trade Rights Enforcement Act of 2005, intellectual property, market access, foreign price controls HR 6111, Tax Relief and Health Care Act of 2006, trade provisions Intellectual property protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills)

S 1926, Animal Enterprise Terrorism Act, research safety HR 4239, Animal Enterprise Terrorism Act, research safety animal health (no bills)

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

S 5, The Class Action Fairness Act of 2005, class action reform S 852, The Fairness in Asbestos Injury Resolution Act of 2005, asbestos litigation S 3734, Multidistrict Litigation Restoration Act, multidistrict legislation

HR 2122, The Project BioShield Act of 2003, pharmaceutical research and development, security S 3807, Enhancing Drug Safety and Innovation Act of 2006, drug safety, DTC

HR 1215 Green Chemistry Research and Development Act of 2005, environmental conservation S 1270, Green Chemistry Research and Development Act of 2005, environmental conservation

HR 2206, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools HR 2744, Agriculture Appropriations, pharmaceutical counterfeiting, importation S 914, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools

HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues HR 870, The PhRMA Research and Manufacturers Accountability (PhRMA) Act, drug safety S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 470, The Fair Access to Clinical Trials ("FACT") Act of 2005, drug safety S 930, Food and Drug Administration Safety Act of 2005, drug safety HR 5156, Counterfeit Drug Prevention Act, pharmaceutical counterfeiting S 3834, Online Pharmacy Consumer Protection Act of 2006, drug safety HR 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 4157, Better Health Information System Act, health information technology HR 5975, Prescription Drug Effectiveness Act, drug prescriptions S 2699, Neglected Diseases Elimination Act, promote R&D HR 2090, The Food and Drug Administration Improvement Act of 2005, drug safety HR 3196, The Fair Access to Clinical Trials ("RACT") Act of 2005, drug safety HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation, drug safety

HR 1215 Green Chemistry Research and Development Act of 2005, environmental conservation S 1270, Green Chemistry Research and Development Act of 2005, environmental conservation

S 1926, Animal Enterprise Terrorism Act, research safety HR 4239, Animal Enterprise Terrorism Act, research safety animal health (no bills)

HR 2862, Science, State, Justice Appropriations, market access HR 3045, Dominican Republic-Central America-United States Free Trade Agreement Implementation Act, Intellectual property, foreign price controls, market access restrictions HR 3283, Agreement The United States Trade Rights Enforcement Act of 2005, intellectual property, market access, foreign price controls S 307, Agreement The United States Trade Rights Enforcement Act of 2005, intellectual property, market access, foreign price controls HR 6111, Tax Relief and Health Care Act of 2006, trade provisions Intellectual property protection (no bills) International pharmaceutical market access (no bills) WTO accession and implementation issues (no bills) US-Korea Free Trade Agreement (no bills) US-Peru Free Trade Agreement (no bills) US-Columbia Free Trade Agreement (no bills)

H Con Res 95, Budget Reconciliation, pharmaceutical counterfeiting, importation HR 2744, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006, pharmaceutical counterfeiting, importation HR 2862, Science, State, Justice, Commerce, and Related Agencies Appropriations Act, 2006, pharmaceutical counterfeiting, importation HR 3010, Departments of Labor, Health and Human Services, and Education, and related Agencies Appropriations Act, 2006, pharmaceutical counterfeiting, importation S Con Res 18, Budget reconciliation, pharmaceutical counterfeiting, importation S Con Res 83, Budget resolution, non-interference HR 6134, Ryan White Care Act, appropriations S 2339, Ryan White Care Act, appropriations

HR 2206, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools HR 2744, Agriculture Appropriations, pharmaceutical counterfeiting, importation S 914, Veterinary Workforce Expansion Act of 2005, increased funding for veterinary schools

HR 328, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation HR 700, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, imporation, patent issues S 109, Pharmaceutical Market Access Act of 2005, pharmaceutical counterfeiting, importation S 334, Pharmaceutical Market Access and Drug Safety Act of 2005, pharmaceutical counterfeiting, importation, patent issues S 2300, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions HR 6022, Lower PRICED Drugs Act, legislation on pediatric exclusivity, citizens petitions S 3695, To Amend the Federal Food, Drug & Cosmetic Act to prohibit the marketing of authorized generic drugs, authorized generics HR 5993, To Amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs HR 5120, To amend title 35, United States Code, to conform certain filing provisions within the Patent and Trademark Office. HR 5418, To establish a pilot program in certain United States district courts to encourage enhancement of expertise in patent cases among district judges S 3818, Patent Reform Act of 2006 S 3175, Life-Saving Medicines Export Act of 2006, compulsory licensing S 3834, Online Pharmacy Consumer Protection Act of 2006, prescription drugs S 1903, Generic Prescription Drug Fairness Act of 2005, authorized generics and rebates

S 5, The Class Action Fairness Act of 2005, class action reform S 852, The Fairness in Asbestos Injury Resolution Act of 2005, asbestos litigation S 3734, Multidistrict Litigation Restoration Act, multidistrict legislation

HR 3010, Labor, HHS Appropriations, prescription drug benefit, price controls HR 712, Medicare Prescription Drug Sensibility Act, prescription drug benefit S 1932, Deficit Reduction Omnibus Reconciliation Act, prescription drug payment issues S 438, Medicare Access to Rehabilitation Services Act of 2005 Medicare prescription drug benefit implementation (no bills) Medicaid rebates (no bills) Medicaid coverage (no bills)